Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe.
Taylor PC, Fautrel B, Piette Y, Romero-Yuste S, Broen J, Welcker M, Howell O, Rottier E, Zignani M, Van Beneden K, Caporali R, Alten R. Taylor PC, et al. Among authors: howell o. RMD Open. 2022 Dec;8(2):e002658. doi: 10.1136/rmdopen-2022-002658. RMD Open. 2022. PMID: 36549856 Free PMC article.
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor.
Caporali R, Kadakia A, Howell O, Patel J, Milligan J, Strengholt S, Barlow S, Taylor PC. Caporali R, et al. Among authors: howell o. Adv Ther. 2024 Sep;41(9):3706-3721. doi: 10.1007/s12325-024-02948-0. Epub 2024 Aug 7. Adv Ther. 2024. PMID: 39110310 Free PMC article.
Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis.
Magliozzi R, Hametner S, Mastantuono M, Mensi A, Karimian M, Griffiths L, Watkins LM, Poli A, Berti GM, Barusolo E, Bellini B, Rossi S, Gveric D, Stratton JA, Akassoglou K, Magon S, Nicholas R, Reynolds R, Howell OW, Monaco S. Magliozzi R, et al. Among authors: howell ow. Brain Pathol. 2024 Dec 1:e13322. doi: 10.1111/bpa.13322. Online ahead of print. Brain Pathol. 2024. PMID: 39617422
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell OW, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca MA, Tamanti A, Vercellino M, Villar LM, Filippi M, Magliozzi R. Calabrese M, et al. Among authors: howell ow. Ann Neurol. 2024 Jul;96(1):1-20. doi: 10.1002/ana.26913. Epub 2024 Apr 3. Ann Neurol. 2024. PMID: 38568026 Review.
Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development.
Hennegan J, Bryant AH, Griffiths L, Trigano M, Bartley OJM, Bartlett JJ, Minahan C, Abreu de Oliveira WA, Yutuc E, Ntikas S, Bartsocas CS, Markouri M, Antoniadou E, Laina I, Howell OW, Li M, Wang Y, Griffiths WJ, Lane EL, Lelos MJ, Theofilopoulos S. Hennegan J, et al. Among authors: howell ow. iScience. 2023 Dec 7;27(1):108670. doi: 10.1016/j.isci.2023.108670. eCollection 2024 Jan 19. iScience. 2023. PMID: 38155767 Free PMC article.
72 results